Home LiteratureArticle Details
PMID: 3579256 Published · ppublish English Clinical Trial Comparative Study Journal Article Randomized Controlled Trial Research Support, U.S. Gov't, P.H.S.

Comparison of steady-state pharmacokinetics of two dosage regimens of vancomycin in normal volunteers.

Antimicrobial agents and chemotherapy ·Vol. 31 ·No. 3 ·1987-03-00 ·Pages 393-7

Healy DP, Polk RE, Garson ML, Rock DT, Comstock TJ

Abstract

A pharmacokinetic comparison of the two recommended dosages of vancomycin given as multiple doses has not been previously performed. Eleven adult subjects with normal renal function randomly received 500 mg every 6 h (five doses) and, later, 1,000 mg every 12 h (three doses). Each dose was infused over 1 h, and regimens were separated by 1 week. Compared with the two-compartment fit, a three-compartment fit significantly reduced the residual weighted sums of squares. Accumulation occurred for both regimens after repeated dosing and was independent of dose. At steady state, concentrations in serum at 1 h showed little variation for the 1,000- or the 500-mg dose regimen (33.7 +/- 3.8 versus 22.6 +/- 3.2 micrograms/ml); trough concentrations were 7.9 +/- 1.7 versus 11.2 +/- 2.2 micrograms/ml, respectively. With the 1,000-mg dose, the terminal half-life was 7.7 +/- 1.8 h, steady-state area under the curve for the dose interval was 227 +/- 28.3 micrograms X h/ml, and total body clearance was 86.1 +/- 8.9 ml/min per 1.73 m2. The red-man syndrome occurred in 9 of 11 volunteers who received 1,000-mg doses and in none of those who received 500-mg doses. We concluded that vancomycin disposition in healthy adults with normal renal function is best described by a three-compartment model, there is relatively little variation in vancomycin disposition in normal volunteers, significant accumulation occurs with multiple dosing, it is inappropriate to use the same therapeutic window for both regimens, and the pharmacokinetics of vancomycin justify a 12-h dose interval; however, a 1-g dose is associated with a significantly greater incidence of the red-man syndrome.

MeSH Terms
Adult Dose-Response Relationship, Drug Drug Administration Schedule Female Half-Life Humans Kidney Diseases/metabolism Male Monitoring, Physiologic Vancomycin/administration & dosage,adverse effects,metabolism
Chemicals
Vancomycin
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Healy D P
Polk R E
Garson M L
Rock D T
Comstock T J
References (19)
19 references, click to expand
  1. Vancomycin: an update.
    Pharmacotherapy. 1986 Jul-Aug;6(4):153-69 PMID: 3534799
  2. Monitoring vancomycin therapy.
    Drug Intell Clin Pharm. 1986 Oct;20(10):757-61 PMID: 3769763
  3. Adverse effects of vancomycin administered in the perioperative period.
    Mayo Clin Proc. 1986 Sep;61(9):721-4 PMID: 3747614
  4. Serum level monitoring of antibacterial drugs. A review.
    Clin Pharmacokinet. 1984 Nov-Dec;9(6):475-92 PMID: 6391780
  5. Vancomycin pharmacokinetics in critically ill patients.
    J Antimicrob Chemother. 1984 Dec;14 Suppl D:53-7 PMID: 6520066
  6. Vancomycin therapy in patients with impaired renal function: a nomogram for dosage.
    Ann Intern Med. 1981 Mar;94(3):343-6 PMID: 6101256
  7. Vancomycin pharmacokinetics in normal and morbidly obese subjects.
    Antimicrob Agents Chemother. 1982 Apr;21(4):575-80 PMID: 7081978
  8. Vancomycin.
    Mayo Clin Proc. 1983 Feb;58(2):88-91 PMID: 6823162
  9. Laboratory evaluation of five assay methods for vancomycin: bioassay, high-pressure liquid chromatography, fluorescence polarization immunoassay, radioimmunoassay, and fluorescence immunoassay.
    J Clin Microbiol. 1984 Sep;20(3):311-6 PMID: 6386852
  10. Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981.
    Antimicrob Agents Chemother. 1983 Jan;23(1):138-41 PMID: 6219616
  11. ESTRIP, a BASIC computer program for obtaining initial polyexponential parameter estimates.
    J Pharm Sci. 1978 Dec;67(12):1687-91 PMID: 722481
  12. Vancomycin disposition: the importance of age.
    Clin Pharmacol Ther. 1984 Dec;36(6):803-10 PMID: 6499360
  13. Some laboratory and clinical experiences with a new antibiotic, vancomycin.
    Proc Staff Meet Mayo Clin. 1956 Oct 17;31(21):564-82 PMID: 13370625
  14. Vancomycin pharmacokinetics in continuous ambulatory peritoneal dialysis patients with peritonitis.
    Nephron. 1986;43(3):217-22 PMID: 3724930
  15. A simplified dosing method for initiating vancomycin therapy.
    Pharmacotherapy. 1985 Nov-Dec;5(6):340-4 PMID: 4080569
  16. Pharmacokinetics of vancomycin.
    J Antimicrob Chemother. 1984 Dec;14 Suppl D:43-52 PMID: 6394577
  17. Single-dose kinetics of intravenous vancomycin.
    J Clin Pharmacol. 1980 Apr;20(4 Pt 1):197-201 PMID: 7381031
  18. Pharmacokinetics of vancomycin in patients with various degrees of renal function.
    Antimicrob Agents Chemother. 1984 Apr;25(4):433-7 PMID: 6732213
  19. Pharmacokinetics of vancomycin: observations in 28 patients and dosage recommendations.
    Antimicrob Agents Chemother. 1982 Sep;22(3):391-4 PMID: 7137982
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1987-03-00
Pages
393-7
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC174739
Subset
IM
Grants
NCRR NIH HHS · RR00065 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]